secwatch.observer — SEC 8-K summary
======================================

Issuer:     PAVmed Inc. (PAVM)
CIK:        0001624326
Form:       8-K
Filed at:   2026-02-04T23:59:59+00:00
Accession:  0001493152-26-005023
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 1.02, 2.03, 3.02, 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PAVmed closes $30M Series D Preferred and $15M Note, retires all convertible securities
--------------------------------------------------------------------------------

- Gross proceeds $30M from Series D Preferred; warrants exercisable for additional $30M upon positive Medicare LCD for EsoGuard.
- New $15M senior secured note with 15% interest, matures Feb 2029, to existing investor.
- Used $22.3M cash + $15M note to redeem all Series C Preferred and retire convertible debt; net cash $7.7M.
- Series D convertible at $6.50/share; special meeting by April 30, 2026 to seek stockholder approval for conversion.
- Eliminates legacy convertible overhang; PAVmed holds 31M shares of Lucid Diagnostics (Nasdaq: LUCD).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1624326/000149315226005023/0001493152-26-005023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1624326/000149315226005023/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-005023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer